Effectiveness of fibroblast growth factor 23 lowering modalities in chronic kidney disease: a systematic review and meta-analysis.

Kullaya TakkavatakarnThunyatorn WuttiputhanunJeerath PhannajitKearkiat PraditpornsilpaSomchai Eiam-OngPaweena Susantitaphong

Published in: International urology and nephrology (2021)

The present meta-analysis demonstrated that non-calcium-based phosphate binders including sevelamer, lanthanum, and iron-based phosphate binders, iron supplements, calcimimetics, hemoperfusion, and preservation of RRF could effectively reduce FGF23 in CKD patients.

Keyphrases

systematic review
end stage renal disease
chronic kidney disease
newly diagnosed
randomized controlled trial
peritoneal dialysis
prognostic factors
meta analyses
septic shock